4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-22-015663
Options or other derivatives
- CEO and President acquired 722,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KLEMP WALTER V CEO and President | 2022-06-20 | Grant or award · Stock option (right to buy) | +360,000 | 1,035,862 | D | ||
| KLEMP WALTER V CEO and President | 2022-06-20 | Grant or award · Restricted Stock Units | +362,000 | 1,397,862 | D | ||
Loading xslF345X03/rdgdoc.xml…